Dearth of drugs for inflammation

Despite a string of failed agents to treat inflammation, leading cardiologist Professor Stephen Nicholls remains optimistic.

At the annual congress of the Cardiac Society of Australia and New Zealand (CSANZ) in Adelaide he told delegates that previous attempts to counter inflammation, which drives plaque formation, had been unsuccessful but new targets were now in view.

“Inflammatory pathways are